| 发明名称 | Use of pidotimod to treat irritable bowel syndrome | ||
| 摘要 | The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally. | ||
| 申请公布号 | US9446027(B2) | 申请公布日期 | 2016.09.20 |
| 申请号 | US201314781755 | 申请日期 | 2013.04.05 |
| 申请人 | POLICHEM SA | 发明人 | Mailland Federico;Scarci Francesco;Caserini Maurizio |
| 分类号 | A61K31/427;A61K45/06;A61K9/00;A61K47/10;A61K47/12;A61K47/18;A61K9/06;A61K9/08;A61K47/36;A61K9/16;A61K9/20 | 主分类号 | A61K31/427 |
| 代理机构 | Fredrikson & Byron, P.A. | 代理人 | Fredrikson & Byron, P.A. |
| 主权项 | 1. A method of treating irritable bowel syndrome in a patient, comprising administering to the patient pidotimod or a physiologically acceptable salt thereof. | ||
| 地址 | Luxembourg LU | ||